1. Davids, M S, Crawford, E, Weremowicz, S, Comb, M J, Melnick, M B. . STK25 is a candidate gene for pseudopseudohypoparathyroidism. In Genomics, 77, 2-4. doi:. https://pubmed.ncbi.nlm.nih.gov/11543625/
2. Matsuki, Tohru, Iio, Akio, Ueda, Masashi, Howell, Brian W, Nakayama, Atsuo. 2021. STK25 and MST3 Have Overlapping Roles to Regulate Rho GTPases during Cortical Development. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 41, 8887-8903. doi:10.1523/JNEUROSCI.0523-21.2021. https://pubmed.ncbi.nlm.nih.gov/34518307/
3. Jiang, Jiong, Zheng, Ying, Chen, Fenrong, Dong, Lei, Guo, Xiaoyan. 2022. Activation of YAP1 by STK25 contributes to the progression of hepatocellular carcinoma. In Tissue & cell, 76, 101797. doi:10.1016/j.tice.2022.101797. https://pubmed.ncbi.nlm.nih.gov/35421669/
4. Cansby, Emmelie, Magnusson, Elin, Nuñez-Durán, Esther, Borén, Jan, Mahlapuu, Margit. . STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia. In Arteriosclerosis, thrombosis, and vascular biology, 38, 1723-1737. doi:10.1161/ATVBAHA.118.311241. https://pubmed.ncbi.nlm.nih.gov/29930001/
5. Wu, Fan, Gao, Pin, Wu, Wei, Jiang, Beihai, Su, Xiangqian. 2018. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer. In Journal of experimental & clinical cancer research : CR, 37, 144. doi:10.1186/s13046-018-0808-1. https://pubmed.ncbi.nlm.nih.gov/29996891/
6. Lim, Sanghee, Hermance, Nicole, Mudianto, Tenny, Manning, Amity L, Ganem, Neil J. 2019. Identification of the kinase STK25 as an upstream activator of LATS signaling. In Nature communications, 10, 1547. doi:10.1038/s41467-019-09597-w. https://pubmed.ncbi.nlm.nih.gov/30948712/